Artigos de revistas sobre o tema "Pancreatic ductal cancer"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Pancreatic ductal cancer".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Chen, Yan, Huiyun Zhu, Yuqiong Wang, Yingxiao Song, Pingping Zhang, Zhijie Wang, Jun Gao, Zhaoshen Li e Yiqi Du. "MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor". Technology in Cancer Research & Treatment 18 (1 de janeiro de 2019): 153303381882431. http://dx.doi.org/10.1177/1533033818824314.
Texto completo da fonteGonzález-Boja, Iranzu, Antonio Viúdez, Saioa Goñi, Enrique Santamaria, Estefania Carrasco-García, Jairo Pérez-Sanz, Irene Hernández-García et al. "Omics Approaches in Pancreatic Adenocarcinoma". Cancers 11, n.º 8 (25 de julho de 2019): 1052. http://dx.doi.org/10.3390/cancers11081052.
Texto completo da fonteRayn, V. U., M. A. Persidskiy, E. V. Malakhova, I. V. Anuchina, A. A. Khalikova, Ya E. Timofeeva e L. V. Bereshkeeva. "Precursors of pancreatic cancer in background of chronic opisthorchiasis". Medical Science And Education Of Ural 22, n.º 1 (31 de março de 2021): 118–21. http://dx.doi.org/10.36361/1814-8999-2021-22-1-118-121.
Texto completo da fonteMelzer, Michael Karl, Frank Arnold, Katja Stifter, Friedemann Zengerling, Ninel Azoitei, Thomas Seufferlein, Christian Bolenz e Alexander Kleger. "An Immunological Glance on Pancreatic Ductal Adenocarcinoma". International Journal of Molecular Sciences 21, n.º 9 (8 de maio de 2020): 3345. http://dx.doi.org/10.3390/ijms21093345.
Texto completo da fonteDjanani, Angela, Andreas Schmiderer, Lukas Niederreiter, Markus Niederreiter e Herbert Tilg. "Management of ductal pancreatic cancer". European Surgery 51, n.º 3 (15 de maio de 2019): 135–38. http://dx.doi.org/10.1007/s10353-019-0583-z.
Texto completo da fonteSun, Hongzhi, Bo Zhang e Haijun Li. "The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment". Technology in Cancer Research & Treatment 19 (1 de janeiro de 2020): 153303382092096. http://dx.doi.org/10.1177/1533033820920969.
Texto completo da fonteHartl, Leonie, JanWillem Duitman, Hella L. Aberson, Kan Chen, Frederike Dijk, Joris J. T. H. Roelofs, Mark P. G. Dings et al. "CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells". Cancers 12, n.º 9 (7 de setembro de 2020): 2546. http://dx.doi.org/10.3390/cancers12092546.
Texto completo da fontePerkins, Corey Melissa, Jinmai Jiang, Hesamedin Hakimjavadi, Julie K. Bray, Alyssa Gosling, Lais da Silva, Gamze Bulut et al. "Abstract 780: Transcriptional profile of human pancreatic acinar ductal metaplasia". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 780. http://dx.doi.org/10.1158/1538-7445.am2022-780.
Texto completo da fonteShabunin, A. A., A. A. Karpov, E. V. Kizhaev, V. V. Bedin, M. M. Tavobilov, O. V. Paklina e G. R. Setdikova. "Combined surgical treatment of pancreatic head cancer". Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 23, n.º 3 (21 de outubro de 2018): 8–13. http://dx.doi.org/10.16931/1995-5464.201838-13.
Texto completo da fonteJansen, Kristina, Franziska Büscheck, Katharina Moeller, Martina Kluth, Claudia Hube-Magg, Niclas Christian Blessin, Daniel Perez et al. "DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness". PeerJ 9 (3 de agosto de 2021): e11905. http://dx.doi.org/10.7717/peerj.11905.
Texto completo da fonteWei, Honglong, Zongzhen Xu, Feng Liu, Fuhai Wang, Xin Wang, Xueying Sun e Jie Li. "Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial–mesenchymal transition". Tumor Biology 39, n.º 5 (maio de 2017): 101042831769168. http://dx.doi.org/10.1177/1010428317691684.
Texto completo da fonteTamiolakis, Demetrio, Constantine Simopoulos, Athanasia Kotini, Ioannis Venizelos, Theodoros Jivannakis e Nikolaos Papadopoulos. "Pancreatic-Polypeptide in the Human Pancreas: Expression and Quantitative Variation During Development and in Ductal Adenocarcinoma". Acta Medica (Hradec Kralove, Czech Republic) 46, n.º 1 (2003): 9–14. http://dx.doi.org/10.14712/18059694.2019.2.
Texto completo da fonteSharaiha, Reem Z., Jessica Widmer e Michel Kahaleh. "Palliation of Pancreatic Ductal Obstruction in Pancreatic Cancer". Gastrointestinal Endoscopy Clinics of North America 23, n.º 4 (outubro de 2013): 917–23. http://dx.doi.org/10.1016/j.giec.2013.06.010.
Texto completo da fonteAnderson, Eric M., Shant Thomassian, Jun Gong, Andrew Hendifar e Arsen Osipov. "Advances in Pancreatic Ductal Adenocarcinoma Treatment". Cancers 13, n.º 21 (3 de novembro de 2021): 5510. http://dx.doi.org/10.3390/cancers13215510.
Texto completo da fonteClark, Clancy J., Janani S. Arun, Rondell P. Graham, Lizhi Zhang, Michael Farnell e Kaye M. Reid-Lombardo. "Clinical Characteristics and Overall Survival in Patients with Anaplastic Pancreatic Cancer". American Surgeon 80, n.º 2 (fevereiro de 2014): 117–23. http://dx.doi.org/10.1177/000313481408000218.
Texto completo da fonteLi, Shentao, He Li, Weiwei Ge, Kai Song, Chunyu Yuan e Ran Yin. "Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism". Technology in Cancer Research & Treatment 19 (1 de janeiro de 2020): 153303382094323. http://dx.doi.org/10.1177/1533033820943237.
Texto completo da fonteTuveson, DavidA. "Experimental approaches to ductal pancreatic cancer". Hamdan Medical Journal 9, n.º 4 (2016): 277. http://dx.doi.org/10.7707/hmj.693.
Texto completo da fonteLink, Karl-Heinrich, Frank Gansauge, Jürgen Pillasch e Hans-Günther Beger. "Multimodal therapies in ductal pancreatic cancer". International Journal of Pancreatology 21, n.º 1 (fevereiro de 1997): 71–83. http://dx.doi.org/10.1007/bf02785923.
Texto completo da fonteKlapdor, R., U. Klapdor, H. Greten, M. Dietel, H. van Ackeren, B. Kremer e H. W. Schreiber. "Palliative therapy of ductal pancreatic cancer". Journal of Cancer Research and Clinical Oncology 111, S1 (fevereiro de 1986): S87. http://dx.doi.org/10.1007/bf02580116.
Texto completo da fonteSirivatanauksorn, V., Y. Sirivatanauksorn e N. R. Lemoine. "Molecular pattern of ductal pancreatic cancer". Langenbecks Archiv für Chirurgie 383, n.º 2 (1998): 105. http://dx.doi.org/10.1007/s004230050101.
Texto completo da fonteYeo, C. J., e J. L. Cameron. "Prognostic factors in ductal pancreatic cancer". Langenbecks Archiv für Chirurgie 383, n.º 2 (1998): 129. http://dx.doi.org/10.1007/s004230050104.
Texto completo da fonteUshio, Jun, Atsushi Kanno, Eriko Ikeda, Kozue Ando, Hiroki Nagai, Tetsurou Miwata, Yuki Kawasaki et al. "Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors". Diagnostics 11, n.º 3 (20 de março de 2021): 562. http://dx.doi.org/10.3390/diagnostics11030562.
Texto completo da fonteCoppola, Alessandro, Daniela Pozzi e Damiano Caputo. "Novel Biomarkers in Pancreatic Cancer". Cancers 16, n.º 3 (31 de janeiro de 2024): 628. http://dx.doi.org/10.3390/cancers16030628.
Texto completo da fonteCoppola, Alessandro, Tommaso Farolfi, Vincenzo La Vaccara, Roberto Cammarata e Damiano Caputo. "Role of Neoplastic Markers in Pancreatic Adenocarcinoma". Journal of Clinical Medicine 11, n.º 21 (2 de novembro de 2022): 6509. http://dx.doi.org/10.3390/jcm11216509.
Texto completo da fonteVernuccio, Federica, Carlo Messina, Valeria Merz, Roberto Cannella e Massimo Midiri. "Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine". Diagnostics 11, n.º 11 (22 de novembro de 2021): 2166. http://dx.doi.org/10.3390/diagnostics11112166.
Texto completo da fonteShi, Chanjuan, Ralph H. Hruban e Alison P. Klein. "Familial Pancreatic Cancer". Archives of Pathology & Laboratory Medicine 133, n.º 3 (1 de março de 2009): 365–74. http://dx.doi.org/10.5858/133.3.365.
Texto completo da fonteGu, Meichen, Yanli Gao e Pengyu Chang. "KRAS Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas". Cancers 13, n.º 10 (18 de maio de 2021): 2429. http://dx.doi.org/10.3390/cancers13102429.
Texto completo da fonteSatoi, Sohei. "Surgical Treatment of Pancreatic Ductal Adenocarcinoma". Cancers 13, n.º 16 (10 de agosto de 2021): 4015. http://dx.doi.org/10.3390/cancers13164015.
Texto completo da fonteKriz, D., D. Ansari e R. Andersson. "Potential biomarkers for early detection of pancreatic ductal adenocarcinoma". Clinical and Translational Oncology 22, n.º 12 (23 de maio de 2020): 2170–74. http://dx.doi.org/10.1007/s12094-020-02372-0.
Texto completo da fonteCao, Liwei, Chen Huang, Daniel Cui Zhou, Yingwei Hu, Mamie Lih, Sara R. Savage, Karsten Krug et al. "Abstract IA-003: Proteogenomic characterizations of pancreatic ductal adenocarcinoma". Cancer Research 81, n.º 22_Supplement (15 de novembro de 2021): IA—003—IA—003. http://dx.doi.org/10.1158/1538-7445.panca21-ia-003.
Texto completo da fonteYousaf, Muhammad Nadeem, Fizah S. Chaudhary, Amrat Ehsan, Alejandro L. Suarez, Thiruvengadam Muniraj, Priya Jamidar, Harry R. Aslanian e James J. Farrell. "Endoscopic ultrasound (EUS) and the management of pancreatic cancer". BMJ Open Gastroenterology 7, n.º 1 (maio de 2020): e000408. http://dx.doi.org/10.1136/bmjgast-2020-000408.
Texto completo da fonteOttenhof, Niki A., Roeland F. de Wilde, Anirban Maitra, Ralph H. Hruban e G. Johan A. Offerhaus. "Molecular Characteristics of Pancreatic Ductal Adenocarcinoma". Pathology Research International 2011 (27 de março de 2011): 1–16. http://dx.doi.org/10.4061/2011/620601.
Texto completo da fonteMatar, Somer M., Britton C. Goodale, Xiaoying Liu, Annie Katanga, Nicole F. Gallien, Sandra Blazquez, Direna Alonso-Curbelo e Steven D. Leach. "Abstract B112: Single-cell profiling of neoplastic cell populations in a KRAS-initiated zebrafish pancreatic cancer model". Cancer Research 84, n.º 2_Supplement (16 de janeiro de 2024): B112. http://dx.doi.org/10.1158/1538-7445.panca2023-b112.
Texto completo da fonteSun, Hongli, Xianwei Dai e Bing Han. "TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma". Disease Markers 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/317817.
Texto completo da fonteYamasaki, Akio, Kosuke Yanai e Hideya Onishi. "Hypoxia and pancreatic ductal adenocarcinoma". Cancer Letters 484 (agosto de 2020): 9–15. http://dx.doi.org/10.1016/j.canlet.2020.04.018.
Texto completo da fonteWang, Ya-Dong, Jia-Ding Mao, Jun-Feng Wang e Mao-Qi Xu. "MiR-590 Suppresses Proliferation and Induces Apoptosis in Pancreatic Cancer by Targeting High Mobility Group A2". Technology in Cancer Research & Treatment 19 (1 de janeiro de 2020): 153303382092814. http://dx.doi.org/10.1177/1533033820928143.
Texto completo da fonteBubin, Roman, Romans Uljanovs e Ilze Strumfa. "Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma". International Journal of Molecular Sciences 24, n.º 8 (10 de abril de 2023): 7030. http://dx.doi.org/10.3390/ijms24087030.
Texto completo da fonteMessina-Pacheco, J., e A. Gregorieff. "A57 VANISHING PANCREAS: HIPPO-MEDIATED FOCAL REPLACEMENT OF THE EXOCRINE PANCREAS WITH ADIPOSE TISSUE". Journal of the Canadian Association of Gastroenterology 6, Supplement_1 (1 de março de 2023): 31–32. http://dx.doi.org/10.1093/jcag/gwac036.057.
Texto completo da fonteGoggins, Michael. "Molecular Markers of Early Pancreatic Cancer". Journal of Clinical Oncology 23, n.º 20 (10 de julho de 2005): 4524–31. http://dx.doi.org/10.1200/jco.2005.19.711.
Texto completo da fonteYang, Hae-Jun, Bong-Seok Song, Bo-Woong Sim, Yena Jung, Unbin Chae, Dong Gil Lee, Jae-Jin Cha et al. "Establishment and Characterization of Immortalized Miniature Pig Pancreatic Cell Lines Expressing Oncogenic K-RasG12D". International Journal of Molecular Sciences 21, n.º 22 (21 de novembro de 2020): 8820. http://dx.doi.org/10.3390/ijms21228820.
Texto completo da fonteSingh, Gurkaranjot, Drew Kutcher, Rajeshwar Lally e Vikrant Rai. "Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma". Cancers 16, n.º 11 (31 de maio de 2024): 2101. http://dx.doi.org/10.3390/cancers16112101.
Texto completo da fonteMendes, Inês, e Nuno Vale. "Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma". Biomedicines 12, n.º 1 (19 de janeiro de 2024): 227. http://dx.doi.org/10.3390/biomedicines12010227.
Texto completo da fonteCheng, Xianliang, Gang Zhao e Yunqi Zhao. "Combination Immunotherapy Approaches for Pancreatic Cancer Treatment". Canadian Journal of Gastroenterology and Hepatology 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/6240467.
Texto completo da fonteGhanaatgar-Kasbi, Sadaf, Shadi Khorrami, Amir Avan, Seyed A. Aledavoud e Gordon A. Ferns. "Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma". Current Pharmaceutical Design 24, n.º 39 (14 de março de 2019): 4619–25. http://dx.doi.org/10.2174/1381612825666190110145855.
Texto completo da fonteChouari, Tarak, Francesca La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels e Adam Frampton. "Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma". Cancers 15, n.º 17 (25 de agosto de 2023): 4265. http://dx.doi.org/10.3390/cancers15174265.
Texto completo da fonteArshad, Tariq. "A novel RAS inhibitor for pancreatic ductal adenocarcinoma." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e16263-e16263. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16263.
Texto completo da fonteWei, Kongyuan, e Thilo Hackert. "Surgical Treatment of Pancreatic Ductal Adenocarcinoma". Cancers 13, n.º 8 (20 de abril de 2021): 1971. http://dx.doi.org/10.3390/cancers13081971.
Texto completo da fonteKaramitopoulou, Eva. "Molecular Pathology of Pancreatic Cancer". Cancers 14, n.º 6 (16 de março de 2022): 1523. http://dx.doi.org/10.3390/cancers14061523.
Texto completo da fonteKang, Chang Moo, e Woo Jung Lee. "Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?" Cancers 12, n.º 11 (18 de novembro de 2020): 3430. http://dx.doi.org/10.3390/cancers12113430.
Texto completo da fonteMcAllister, Josiah, Saber Amin e Chi Lin. "Association of facility type with overall survival in patients with nonsurgically managed pancreatic cancer". Future Oncology 18, n.º 10 (março de 2022): 1273–84. http://dx.doi.org/10.2217/fon-2021-0986.
Texto completo da fonte